Induced effects by Ruta graveolens L., Rutaceae, Cnidoscolus chayamansa McVaugh, Euphorbiaceae, and Citrus aurantium L., Rutaceae, on glucose, cholesterol and triacylglycerides levels in a diabetic rat model;Efectos inducidos por Ruta graveolens L., Cnidoscolus chayamansa McVaugh y Citrus aurantium L. sobre los niveles de glucosa, colesterol y triacilglicéridos en un modelo de rata diabética

Revista Brasileira de Farmacognosia

Volumn 19, Issue 4, 2009, Pages 898-907

  Figueroa Valverde, Lauro ^a   Díaz Cedillo, Francisco ^b   Camacho Luis, Abelardo ^c   López Ramos, Maria ^a  

^a UNIVERSIDAD AUTÓNOMA DE CAMPECHE   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c Facultad Mexicana de Medicina de la Universidad   (Mexico)

Author keywords

Citrus aurantium; Cnidoscolus chayamansa; Diabetes; Ruta graveolens; Wistar

Indexed keywords

CHOLESTEROL; CNIDOSCOLUS CHAYAMANSA EXTRACT; GLUCOSE; PLANT EXTRACT; RUTA GRAVEOLENS EXTRACT; SOUR ORANGE EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CNIDOSCOLUS CHAYAMANSA; CONTROLLED STUDY; DOSE RESPONSE; EUPHORBIA; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; LIPID BLOOD LEVEL; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; RUTA GRAVEOLENS; SOUR ORANGE; STANDARD; TRADITIONAL MEDICINE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 77949536174     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0102-695X2009000600019     Document Type: Article

References (48)

1. Agraa SE, Badwi SM, Adam SE 2002. Preliminary observations on experimental Ruta graveolens toxicosis in Nubian goats. Trop Anim Health Pro 34: 271-81.
2. Allain CC, Poon L, Chan SG, Richmond W, Fu P 1974. Enzymatic determination of total serum cholesterol. Clin Chem 20: 470-475.
3. Andrade A, Wiedenfeld H 2001. Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats. J Ethnopharmacol 78: 145-149.
4. Bayne K 1996. Revised guide for the care and use of laboratory animals available. Am Physiol Soc Physiol 39: 208-211.
5. Baynes J 1991. Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412.
6. Buccolo G, David H 1973. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19: 476-482.
7. Cheng Z, Jing C, Li-Na G, Yong C 2008. Influence of dihydromyricetin on the blood glucose concentration and early kidney's damage in impaired glucose tolerance rats. Jingxi Hua Gong 25: 966-969.
8. Colker C, Kalman D, Torina G, Perlis T 1999. Effects of Citrus aurantium extract, caffeine, and St. John's Wort on body fat loss, lipid levels, and mood states in overweight healthy adults. Curr Ther Res Clin E 60: 121-153.
9. Coronado G, Thompson B, Tejeda S, Godina R 2004. Attitudes and beliefs among mexican americans about type 2 diabetes. J Health Care Poor U 15: 576-588.
10. Dyer A, Stamler J, Berkson O, Lepper M, McKean H 1977. Alcohol consumption, cardiovascular risk factors, and mortality in two Chicago epidemiologic studies. Circulation 56: 1067-1074.
11. Ezzati M, Henley J, Thun M, Lopez A 2005. Ole of smoking in global and regional cardiovascular mortality. Circulation 112: 489-497.
12. Fossati P, Prencipe L 1982. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28: 2077-2080.
13. Fugh-Berman A, Myers A 2004. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Exp Biol Med 229: 698-704.
14. Funke I, Melzig M 2006. Traditionally used plants in diabetes therapy-phytotherapeutics as inhibitors of a-amylase activity. Rev Bras Farmacogn 16: 1-5.
15. Gaziano AT 2005. Cardiovascular disease in the developing world and its cost-effective management. Circulation 112: 3547-3553.
16. Gonzales R, Flores M, Quintero M, Karchesy J 2003. Flavonoid and cyanogenic contents of Chaya (Spinach Tree). Plant Food Hum Nutr 58: 1-8.
17. Gordon D, Probstfield J, Garrison R, Neaton J, Castelli W, Knoke J 1989. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective american studies. Circulation 79: 8-15.
18. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR 1998. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The third national health and nutrition examination survey, 1988-1994. Diabetes Care 21: 518-24.
19. Hawkins R 2005. Evaluation of roche accu-chek go and medisense optium blood glucose meters. Clin Chim Acta 353: 127-135.
20. Hawthorne S, Grabanski C, Martin E, Miller D 2000. Comparisons of Soxhlet extraction, pressurized liquid extraction, supercritical fluid extraction and subcritical water extraction for environmental solids: recovery, selectivity and effects on sample matrix. J Chromatogr 892: 421-433.
21. Heimler D, Pieron A, Tattini M, Cimato A 1992. Determination of flavonoids, flavonoid glycosides and biflavonoids in Olea europae L. leavels. Chromatographie 33: 349-373.
22. Hitchcock P, Pugh J, Larme A, Marsh G 1997. The use of traditional plant medicines for non-insulin dependent diabetes mellitus in south Texas. Phytother Res 11: 512-517.
23. Je H, Shin C, Park S, Yim S, Kum C 2002. Combination of vitamin C and rutin on neuropathy and lung damage of diabetes mellitus rats. Arch Pharm Res 25:184-190.
24. Jong K, Chong K, Kun S 2000. Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid. Biosci Biotech Bioch 64: 2458-2461.
25. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM 2002. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med 346: 393-403.
26. Lott J, Turner K 1975. Evaluation of trinder's glucose oxidase method for measuring glucose in serum and urine. Clin Chem 21: 1754-1760.
27. Mahabir D, Gulliford M 1997. Use of medicinal plants for diabetes in Trinidad and Tobago. Rev Panam Salud Publica 1: 174-179.
28. Moller D 2001. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414: 821-827.
29. Nuraliev I, Avezov GA 1992. The efficacy of quercetin in alloxan diabetes. Eksp Klin Farmakol 55: 42-44.
30. Oliveira E, Silva D, Gonçalves S, Danni F 1998. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837-53.
31. O'Sullivan D, Cashman W 1970. Blood glucose variations and clinical experience with glibenclamide in diabetes mellitus. Brit Med J 2: 572-574.
32. Palos SG del Rosario 2007. Evaluación de la actividad antioxidante de la chaya (Cnidoscolus chayamansa) en un modelo experimental de diabetes en ratas wistar. Tesis Maestria en Tecnología Avanzada No. A50074. cicata-qro p. 1-106.
33. Penicaud L, Hitier Y, Ferre P, Girard J 1989. Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine. Biochem J 262: 881-885.
34. Pérez R, Pérez C, Zavala M 1998. Actividad hipoglucemiante de Bouvardia terniflora, Brickellia veronicaefolia y Parmentiera edulis. Salud Publ Mex 40: 354-358.
35. Rajasekaran S, Sivagnanam K, Subramanian S 2005. Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol Rep 57: 90-96.
36. Rates S 2001. Plants as source of drugs. Toxicon 39: 603-613.
37. Rubin RJ, Altman WM, Mendelson DN 1994. Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocr Metab 78: 809A-809F.
38. Saieed P, Reza R, Abbas D, Seyyedvali R 2006. Inhibitory effects of Ruta graveolens L. extract on guinea pig liver aldehyde oxidase. Chem Pharm Bull 54: 9-13.
39. Salpeter S, Greyber E, Pasternak G, Salpeter E 2003. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Arch Intern Med 163: 2594-2602.
40. Santos K, Oliveira T, Nagem T, Pinto A, Oliveira M 1999. hypolipidaemic effects of naringenin, rutin, nicotinic acid and their associations. Pharmacol Res 40: 493-496.
41. Sharma M, Fernandes J, Ahirwar D, Jain R 2008. Hypoglycemic and hypolipidimic activity of alcoholic extract of Citrus aurantium in normal and alloxan-induced diabetic rats. Pharmacologyonline 3: 161-171.
42. Siguira M, Ogawa K, Masamichi Y 2006. Effect of chronic administration of fruit extract (Citrus unshiu Marc.) on glucose tolerance in GK rats, a model of type 2 diabetes. Biosci Biotech Bioch 70: 293-295.
43. Singh P, Kar A 2007. Antidiabetic potential of Citrus sinensis and Punica granatum peel extracts in alloxan treated male mice. Biofactors 31: 17-24.
44. Srinath R, Yusuf S 1998. Emerging epidemic of cardiovascular disease in developing countries. Circulation 97: 596-601.
45. Srinivasan K, Kaul C, Ramarao P 2005. Partial protective effect of rutin on multiple low dose streptozotocin-induced diabetes in mice. Indian J Pharmacol 37: 327-328.
46. Stamler J, Vaccaro O, Neaton JD, Wentworth D 1993. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16: 434-44.
47. Wongpaitoon V, Mills P, Russell R, Patrick R 1981. Intrahepatic cholestasis and cutaneous bullae associated with glibenclamide therapy. Postgrad Med J 57: 244-246.
48. Zárate A, Tene C 1999. Nuevos fármacos en el tratamiento de la diabetes mellitus tipo 2. Gac Med Mex 135: 91-93.